Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 65,153 $ 77,258
Accounts receivable 200
Prepaid expenses, deposits, and other current assets 5,662 5,179
Total current assets 70,815 82,637
Fixed assets, net 2,253 1,585
Operating lease right-of-use assets 3,205
Intangible assets, net 4,456 2,029
Other assets 1,725 725
Total assets 82,454 86,976
Current liabilities:    
Accounts payable 4,492 3,299
Accrued expenses and other current liabilities 2,932 4,259
Operating lease liabilities, current portion 943
Senior Secured Convertible Notes - at fair value 29,500
Purchase consideration payable 1,000
Total current liabilities 38,867 7,558
Long-term liabilities    
Operating lease liabilities, less current portion 2,183
Total long-term liabilities 2,183
Total liabilities 41,050 7,558
Commitments and contingencies (Note 9)  
Stockholders’ Equity:    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,158,950 at June 30, 2022 and 1,113,919 shares at December 31, 2021 2,554 2,419
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 87,023,211 and 86,367,845 shares outstanding as of June 30, 2022 and December 31, 2021, respectively 87 86
Additional paid-in capital 201,327 198,071
Accumulated deficit (181,442) (138,910)
Treasury stock (548)
Total PAVmed Inc. Stockholders’ Equity 21,978 61,666
Noncontrolling interests 19,426 17,752
Total Stockholders’ Equity 41,404 79,418
Total Liabilities and Stockholders’ Equity $ 82,454 $ 86,976